Literature DB >> 29478673

Interaction Between Depression, Obesity, and Type 2 Diabetes: A Complex Picture.

Magdalena Del Rocío Sevilla-González1, Brenda Macale Quintana-Mendoza1, Carlos Alberto Aguilar-Salinas2.   

Abstract

Depression plays an important role in the pathogenesis and treatment of obesity and type 2 diabetes (T2D). However, its relevance is frequently unrecognized by clinicians and researchers. The purpose of this review is to present a critical analysis of the evidence linking depression and metabolic disorders and to highlight the practical implications of this complex relationship. Evidence obtained from epidemiological, basic, clinical and controlled studies demonstrate that the association goes beyond a random phenomenon. Epidemiological studies have rendered controversial results due to the lack of control of the confounding variables and the bidirectional relationship that exists between the outcomes and the conditions that modulate the association (i.e. socioeconomic status). Animal and human studies have been useful to define the anatomic substrates and physiologic processes that participate in the association, but, the evidence is preliminary in many areas (i.e gene × environmental interactions). Controlled studies have shown the strong impact that treatment of depression has on body weight and the large effect that has the correction of excess body weight on the depression-related symptoms. Practical implications of the depression-obesity duet include the training of the health providers to assess and treat these conditions in a concomitant manner, the need for translational medicine projects and the application the systems biology approach to fill the existing gaps of knowledge.
Copyright © 2018 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Body weight; Depression; Obesity; Type 2 diabetes

Mesh:

Year:  2018        PMID: 29478673     DOI: 10.1016/j.arcmed.2018.02.004

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  8 in total

1.  Antiobesity, Antihyperglycemic, and Antidepressive Potentiality of Rice Fermented Food Through Modulation of Intestinal Microbiota.

Authors:  Papan Kumar Hor; Shilpee Pal; Joy Mondal; Suman Kumar Halder; Kuntal Ghosh; Sourav Santra; Mousumi Ray; Debabrata Goswami; Sudipta Chakrabarti; Somnath Singh; Sanjai K Dwivedi; Miklós Takó; Debabrata Bera; Keshab Chandra Mondal
Journal:  Front Microbiol       Date:  2022-05-06       Impact factor: 6.064

2.  Multidimensional analysis of health in Mexico: implementation of fuzzy sets.

Authors:  Lucio Flores-Payan; Diana Mercedes Hernández-Corona; Tonatiuh González-Heredia
Journal:  BMC Public Health       Date:  2021-05-19       Impact factor: 3.295

3.  DIVE/DPV registries: benefits and risks of analog insulin use in individuals 75 years and older with type 2 diabetes mellitus.

Authors:  Gesine van Mark; Sascha R Tittel; Reinhard Welp; Jörg Gloyer; Stefan Sziegoleit; Ralf Barion; Peter M Jehle; Dieter Erath; Peter Bramlage; Stefanie Lanzinger
Journal:  BMJ Open Diabetes Res Care       Date:  2021-06

4.  Comorbid Depression and Obesity: Correlates and Synergistic Association With Noncommunicable Diseases Among Australian Men.

Authors:  Tilahun Nigatu Haregu; John Tayu Lee; Brian Oldenburg; Gregory Armstrong
Journal:  Prev Chronic Dis       Date:  2020-07-02       Impact factor: 2.830

5.  The contribution of type 2 diabetes mellitus to hypothalamic inflammation and depressive disorders in young patients with obesity.

Authors:  Guan-Zhong Dong; Qiao-Yang Zhang; Yu-Wen Jiao; Yi Ma; Shu-Min Zhu; Li-Hao Zhang; Min Zhang; Yun Chen; Xin-Hua Ye; Yin Cao; Li-Ming Tang
Journal:  Ann Transl Med       Date:  2022-02

6.  Comorbidity Between Recent Diagnosis of Type 2 Diabetes and Non-Psychotic Psychiatric Disorders: Metabolic Characteristics and Clinical Correlates.

Authors:  María Teresa Alcántara-Garcés; Alejandra Monserrat Rodríguez-Ramírez; Ana Cristina García-Ulloa; Sergio Hernández-Jiménez
Journal:  Neuropsychiatr Dis Treat       Date:  2022-06-12       Impact factor: 2.989

7.  Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink.

Authors:  John-Michael Gamble; Eugene Chibrikov; William K Midodzi; Laurie K Twells; Sumit R Majumdar
Journal:  BMJ Open       Date:  2018-10-08       Impact factor: 2.692

8.  High Bodyweight Variability Increases Depression Risk in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study in Korea.

Authors:  Ji Hyun An; Kyung-do Han; Jin-Hyung Jung; Juhwan Yoo; Maurizio Fava; David Mischoulon; Su-Min Jung; Dong Wook Shin; Kyu Yeon Hur; Hong Jin Jeon
Journal:  Front Psychiatry       Date:  2021-12-10       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.